222 – What’s New in Psychopharmacology?

Separating Myths from Reality
Frank Anderson

With so many controversies and contradictory research about the effectiveness of psychopharmacological interventions, it’s hard to know how to best work with your clients around the issue of meds. What are the new most promising medications on the market? Are antidepressants really any better than placebos? Why are so many clients prescribed antipsychotics these days? What are the prospects of breakthroughs in the next generation of meds? Discover the answers to these questions and more in this comprehensive workshop. You’ll explore the latest information about:

  • How different kinds of medications affect the brain and nervous system
  • Current best prescribing practices for treating depression, bipolar disorder, anxiety, PTSD, dissociation, psychotic disorders, insomnia, ADHD, and more
  • New drugs on the market as well as the next generation of psychoactive meds


Frank Anderson, MD, is a psychiatrist as well as a psychotherapist. He’s the executive director of the Foundation for Self Leadership and a supervisor at the Trauma Center at Justice Resource Institute.

Speaker Disclosures:
Financial: Frank Anderson maintains a private practice. He receives a consulting fee from the Center for Self Leadership. Dr. Anderson receives a speaking honorarium from PESI, Inc.
Non-financial: Frank Anderson is the President of the Foundation for Self Leadership.

Scroll to Top